Clorox
Latest news and updates related to clorox
About Clorox coverage
The Clorox news hub on Global Investing News tracks 4 recent headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Clorox developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Clorox across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Clorox headlines
Market Data
(3)Wells Fargo Raises its Price Target on The Clorox Company (CLX) to $125 and Maintains an Equal Weight Rating
Wells Fargo Raises its Price Target on The Clorox Company (CLX) to $125 and Maintains an Equal Weight Rating
Clorox to buy Purell maker for more than $2 billion, eyeing 20 million hand-sanitizer dispensers and more
Clorox’s acquisition of GOJO Industries, the maker of Purell, for over $2 billion represents a strategic pivot toward recurring revenue streams in the professional and institutional hygiene sectors. While Clorox remains a powerhouse in the consumer retail space, this deal significantly expands its footprint in high-traffic commercial environments—such as hospitals, airports, and schools—via Purell's massive installed base of 20 million dispensers. This 'razor-and-blade' model ensures long-term contract stability and consistent demand for refill consumables, which are less susceptible to the cyclicality of consumer spending. Historically, Clorox saw a massive demand surge during the COVID-19 pandemic followed by a painful normalization period; this acquisition suggests management is repositioning the portfolio to capture permanent shifts in public health standards. For investors, the significance lies in the synergy between Clorox’s industrial-scale supply chain and Purell’s market-leading brand equity. Watch for how Clorox manages the integration of GOJO's manufacturing facilities and whether they can leverage this acquisition to cross-sell other professional-grade cleaning products into GOJO’s existing distribution networks.
Clorox to Buy Hand Sanitizer Maker for $2.25 Billion
Clorox’s $2.25 billion acquisition of a leading hand sanitizer manufacturer marks a strategic pivot toward permanent integration into the professional and consumer hygiene markets. For investors, this move signifies Clorox’s intent to diversify away from its traditional bleach-centric portfolio and capture a larger share of the wellness and institutional safety sectors, which have seen structurally higher baseline demand following the global pandemic. The deal comes at a time when consumer staples companies are under pressure to prove that 'pandemic-era' growth can be sustained through strategic M&A rather than just price hikes. By absorbing a specialized manufacturer, Clorox gains immediate vertical integration, potentially improving margins through supply chain efficiencies and expanded distribution in healthcare and hospitality channels. However, the valuation suggests Clorox is paying a premium for market leadership, placing the onus on management to deliver on projected synergies. Investors should monitor how this acquisition affects Clorox's debt-to-EBITDA ratio and whether it signals a tapering of its share buyback program. Moving forward, the key metric will be the retention rate of institutional contracts as the hygiene market shifts from crisis-response to long-term safety protocols.
Get alerts for this topic
Subscribe to receive updates about "Clorox"